19736 S0289 M1 1571

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

3

Download PDF ↗ Live URL (may be dead)

Document text

BioNTech SE 04/15/2021
An der Goldgrube 12
Mainz Rhineland-Palatinate
Germany 55131(212) 733-2613
COVID-19 Vaccine (BNT162, PF-07302048) 019736
Prophylactic immunization against COVID-19 in adults 
16 years of age
0 2 8 8
Summary Monthly Safety Report (SMSR)
3
FDA-CBER-2021 5683-1084590
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE 
Neda Aghajani Memar, Senior Manager, Pfizer Global Regulatory Affairs - Vaccines
(212) 733-2613 (845) 474-3500 
235 East 42nd Street 
 
New York NY
United States of America [email protected] 
04/15/2021
United States of America
3
(b) (6)
FDA-CBER-2021-5683-1084591
3
FDA-CBER-2021-5683-1084592